Literature DB >> 8637524

A reversible posterior leukoencephalopathy syndrome.

R B Schwartz.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8637524     DOI： 10.1056/NEJM199606273342613

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 2.  Neurology and the kidney.

Authors:  D J Burn; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

3.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

4.  Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré Syndrome.

Authors:  Ali Elahi; Praful Kelkar; Erik K St Louis
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

5.  Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma.

Authors:  Jamal Oulad Hadj; Rogier DEN Braven; Corrine Tillier; Hans M Schrijver; Henk M W Verheul; Hans J VAN DER Vliet
Journal:  Oncol Lett       Date:  2012-03-16       Impact factor: 2.967

Review 6.  Posterior leukoencephalopathy syndrome.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

Review 7.  Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Authors:  Joan How; Margaret Blattner; Susan Fowler; Andrea Wang-Gillam; Suzanne E Schindler
Journal:  Neurologist       Date:  2016-11       Impact factor: 1.398

8.  Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.

Authors:  S A Ryan; P Maceneaney; S P O'Reilly; E J Moylan; D G Power
Journal:  Med Oncol       Date:  2011-03-10       Impact factor: 3.064

9.  Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women.

Authors:  Sarah N Cross; Elena Ratner; Thomas J Rutherford; Peter E Schwartz; Errol R Norwitz
Journal:  Rev Obstet Gynecol       Date:  2012

10.  CT perfusion imaging in the management of posterior reversible encephalopathy.

Authors:  S O Casey; A McKinney; M Teksam; H Liu; C L Truwit
Journal:  Neuroradiology       Date:  2004-03-26       Impact factor: 2.804
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.